Compare AYTU & RMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AYTU | RMTI |
|---|---|---|
| Founded | N/A | 1994 |
| Country | United States | United States |
| Employees | N/A | 300 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 27.4M | 26.7M |
| IPO Year | 2015 | 2022 |
| Metric | AYTU | RMTI |
|---|---|---|
| Price | $2.16 | $5.25 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $9.33 | $2.00 |
| AVG Volume (30 Days) | 23.4K | ★ 327.9K |
| Earning Date | 05-13-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $27,632,080.00 | ★ $69,258,000.00 |
| Revenue This Year | N/A | $8.64 |
| Revenue Next Year | $43.75 | $8.44 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 277.47 | N/A |
| 52 Week Low | $1.65 | $0.55 |
| 52 Week High | $3.07 | $5.69 |
| Indicator | AYTU | RMTI |
|---|---|---|
| Relative Strength Index (RSI) | 45.37 | 95.98 |
| Support Level | $2.08 | $0.82 |
| Resistance Level | $2.32 | N/A |
| Average True Range (ATR) | 0.09 | 0.12 |
| MACD | 0.00 | 0.48 |
| Stochastic Oscillator | 33.39 | 97.08 |
Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline, including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates one business segment consisting of various prescription pharmaceutical products sold through third parties.
Rockwell Medical Inc is a healthcare company that develops, manufactures, commercializes, and distributes a portfolio of hemodialysis products for dialysis providers. It is a supplier of liquid bicarbonate concentrates, acid, and dry bicarbonate concentrates for dialysis patients in the United States. The company's products include CitraPure citric acid concentrate, RenalPure liquid acid concentrate, and SteriLyte bicarbonate concentrate, among others. The company delivers the majority of its hemodialysis concentrates products and mixers to dialysis clinics throughout the United States and internationally, utilizing its own delivery trucks and third-party carriers.